← USPTO Patent Applications

KARYOCREATE (KARYOTYPE CRISPR ENGINEERED ANEUPLOIDY TECHNOLOGY)

Application US20260085330A1 Kind: A1 Mar 26, 2026

Inventors

Teresa DAVOLI, Nazario BOSCO

Abstract

Provided are a fusion protein comprising a mutated kinetochore protein and dCas9. The fusion protein is used in conjunction with guide RNAs target the fusion protein to a location of kinetochore assembly on a centromere such that the fusion protein interferes with chromosome segregation. Use of the fusion protein and the guide RNAs in cells results the cells acquiring an aneuploidy karyotype. Expression vectors that encode the fusion proteins and/or the guide RNAs and their uses in the method of producing an aneuploidy karyotype are also provided.

CPC Classifications

C12N 15/907 C07K 14/46 C12N 9/226 C12N 15/11 C07K 2319/00 C12N 2310/20

Filing Date

2023-09-08

Application No.

19109981